Unisys Recognized Among Top Employers in Asia-Pacific by Financial Times for Employee Experience

2024-12-19 IDOPRESS

BLUE BELL,Pa.,Dec. 18,2024 --Unisys(NYSE: UIS)announced that the Financial Times has recognized the company as one of 2025 Best Employers to work for in Asia Pacific,placing Unisys in the top 35% of the 500 employers in the ranking. Represented by employees in more than thirty countries,this recognition underscores Unisys' commitment to fostering connections and understanding and valuing the employee experience worldwide.

"We are honored to be recognized as a premier employer in the Asia-Pacific region,a testament to our unwavering support for our global workforce," said Ruchi Kulhari,senior vice president and chief human resources officer at Unisys. "At Unisys,we are passionate about nurturing meaningful connections and providing a well-rounded employee experience worldwide. This recognition speaks to our dedication to building an environment where every team member feels valued,supported,and empowered to achieve their best."

Unisys fosters a winning culture by encouraging and celebrating employees who experiment and explore. To reinforce this,the company has established an environment of continuous learning,offering virtual and instructor-led training in business,technology and leadership practices. Additionally,employee-led forums facilitate individuals' sharing of expertise across business units.

To create the first edition of the Best Employers in Asia-Pacific list,the Financial Times collaborated with data provider Statista to conduct an extensive survey between May and July 2024,gathering insights from over 50,000 employees across various Asia-Pacific countries. The survey evaluated more than 300,000 individual assessments,focusing on employees' willingness to recommend their employers and their perceptions of other companies within their sector.

Clickhereto learn more about theFinancial Times list of Best Employers in Asia-Pacific.

About Unisys

Unisys is a global technology solutions company that powers breakthroughs for the world's leading organizations. Our solutions – cloud,AI,digital workplace,logistics and enterprise computing – help our clients challenge the status quo and unlock their full potential. To learn how we have been helping clients push what's possible for more than 150 years,visitunisys.com and follow us on LinkedIn.

RELEASE NO.: 1217/9979

Unisys and other Unisys products and services mentioned herein,as well as their respective logos,are trademarks or registered trademarks of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.

UIS-C

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map